Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11103758 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Peg-interferon

Indicates status has not been verified in more than two years